Henry Ford Hospital thought leaders regularly speak at the cardiology conferences about new research and technology innovations. So, it was an honor when DAIC was invited to conduct a site visit at Henry Ford recently to tour its facilities, sit in on procedures and conduct numerous video interviews to better understand the workings of the institution. 


I recently had the opportunity to conduct an onsite visit to the University of Colorado Hospital Heart and Vascular Center at the Anschutz Medical Campus in Aurora, Colo., which is part of UCHealth.

Dec. 11, 2025 — Heartflow, Inc., a provider of AI technology for coronary artery disease (CAD), recently announced two new analyses from FISH&CHIPS, a real-world, multicenter, retrospective study of more than 90,000 patients conducted by the National Health Service (NHS) in England, representing the largest fractional flow reserve (FFRCT) study ever conducted.

Dec. 8, 2025 — In November, The Lancet published an international expert consensus review, “Contemporary, non-invasive imaging diagnosis of chronic coronary artery disease”, that shows using CT coronary angiography (CTCA) when patients exhibit low to intermediate pre-test probabilities (PTP) for coronary disease can lead to more cardiac patients being accurately diagnosed, which helps save lives.  Currently, the testing is not readily available at many medical facilities, and guidelines generally recommend against routine testing for low PTP (<5%).

Dec. 10, 2025 — The Singapore-MIT Alliance for Research and Technology (SMART), Massachusetts Institute of Technology’s (MIT) research enterprise in Singapore, has launched a new collaborative research project – Wearable Imaging for Transforming Elderly Care (WITEC).

Nov. 25, 2025 — Remington Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance and announced the commercial launch of the second-generation VascuChek Doppler. VascuChek is a handheld vascular Doppler device for clinical and surgical use. With the addition of a Bluetooth external speaker, VascuChek 2.0 gives clinicians and surgeons superior audio clarity and volume to more accurately assess patients’ blood flow during surgeries.

Nov. 30, 2025 – Ascend Cardiovascular, a provider of purpose-built enterprise imaging for cardiology, and Konica Minolta Healthcare Americas, Inc., a provider of medical diagnostic imaging and healthcare IT solutions, have announced a strategic partnership to deliver a unified and complete enterprise imaging solution for hospital cardiology departments and cardiology practices.

Dec. 3, 2025 — Atraverse Medical, a medical device company developing next-generation left-heart access technology, has received 510(k) clearance from the U.S. FDA for its fully integrated HOTWIRE Transseptal Access System. 

Dec. 3, 2025 — Recross Cardio Inc., a structural heart company developing next-generation membrane sealing technology, recently announced the first clinical implantation with its novel PFO Sealing system in the PROTEA-PFO Early Feasibility Study (EFS). The procedure was successfully performed by Dr. Carey Kimmelstiel and his interventional team at Tufts Medical Center in Boston, Massachusetts.

Dec. 2, 2025 — At RSNA 2025, Siemens Healthineers announced Syngo.CT Coronary Cockpit1, a new software solution within the Syngo.via2 platform designed to support the management of coronary artery disease (CAD) for both dual-source and photon-counting CT scanners. As the leading cause of death globally and a major contributor to disability,3 CAD continues to pose a significant global health challenge. This drives increasing demand for diagnostic and treatment planning tools that are both efficient and minimally invasive.

Subscribe Now